LWM
PFE icon

LeConte Wealth Management’s Pfizer PFE Stock Holding History

LeConte Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Sell
8,331
-2,018
-19% -$52.8K 0.11% 167
2026
Q1 		$291K Buy
10,349
+2,168
+27% +$57.7K 0.19% 94
2025
Q4 		$204K Buy
+8,181
New +$206K 0.13% 132

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LeConte Wealth Management's PFE Position: Q2 2026 in Review

LeConte Wealth Management reduced its Pfizer (PFE) stake by 19% in Q2 2026, selling an estimated $52.8K and leaving 8,331 shares worth $201K. The position accounts for 0.11% of the portfolio, ranked #167.

LeConte Wealth Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $291K in Q1 2026. 2,830 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LeConte Wealth Management held 8,331 shares of Pfizer worth $201K as of Q2 2026.
  • LeConte Wealth Management sold 2,018 Pfizer shares in Q2 2026, an estimated $52.8K.
  • Pfizer made up 0.11% of LeConte Wealth Management's portfolio in Q2 2026, its #167 holding.
  • LeConte Wealth Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • LeConte Wealth Management's Pfizer position peaked at $291K in Q1 2026.
  • 2,830 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LeConte Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.